Clinical assessment and outcome scales in acute stroke

J. M. Hourihane, Wayne Clark

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

This article reviews both the commonly used functional outcome scales and the detailed neurologic deficit scales that are currently employed in stroke therapeutic efficacy trials. Both types of scales have their apparent advantages, with the neurologic scales being able to detect smaller changes in the patient's neurologic function, whereas the functional outcome scales appear to have more relevance to the patient's ability to function independently. Clearly, both types of scales also possess weaknesses, and to date there is no agreement on a single gold standard for measuring a drug's therapeutic efficacy after a stroke.

Original languageEnglish (US)
Pages (from-to)539-552
Number of pages14
JournalNeuroimaging Clinics of North America
Volume9
Issue number3
StatePublished - 1999

Fingerprint

Nervous System
Stroke
Outcome Assessment (Health Care)
Neurologic Manifestations
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology
  • Radiological and Ultrasound Technology

Cite this

Clinical assessment and outcome scales in acute stroke. / Hourihane, J. M.; Clark, Wayne.

In: Neuroimaging Clinics of North America, Vol. 9, No. 3, 1999, p. 539-552.

Research output: Contribution to journalArticle

@article{b478106fae3a4ba4a3afa62e4f9f76f8,
title = "Clinical assessment and outcome scales in acute stroke",
abstract = "This article reviews both the commonly used functional outcome scales and the detailed neurologic deficit scales that are currently employed in stroke therapeutic efficacy trials. Both types of scales have their apparent advantages, with the neurologic scales being able to detect smaller changes in the patient's neurologic function, whereas the functional outcome scales appear to have more relevance to the patient's ability to function independently. Clearly, both types of scales also possess weaknesses, and to date there is no agreement on a single gold standard for measuring a drug's therapeutic efficacy after a stroke.",
author = "Hourihane, {J. M.} and Wayne Clark",
year = "1999",
language = "English (US)",
volume = "9",
pages = "539--552",
journal = "Neuroimaging Clinics of North America",
issn = "1052-5149",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Clinical assessment and outcome scales in acute stroke

AU - Hourihane, J. M.

AU - Clark, Wayne

PY - 1999

Y1 - 1999

N2 - This article reviews both the commonly used functional outcome scales and the detailed neurologic deficit scales that are currently employed in stroke therapeutic efficacy trials. Both types of scales have their apparent advantages, with the neurologic scales being able to detect smaller changes in the patient's neurologic function, whereas the functional outcome scales appear to have more relevance to the patient's ability to function independently. Clearly, both types of scales also possess weaknesses, and to date there is no agreement on a single gold standard for measuring a drug's therapeutic efficacy after a stroke.

AB - This article reviews both the commonly used functional outcome scales and the detailed neurologic deficit scales that are currently employed in stroke therapeutic efficacy trials. Both types of scales have their apparent advantages, with the neurologic scales being able to detect smaller changes in the patient's neurologic function, whereas the functional outcome scales appear to have more relevance to the patient's ability to function independently. Clearly, both types of scales also possess weaknesses, and to date there is no agreement on a single gold standard for measuring a drug's therapeutic efficacy after a stroke.

UR - http://www.scopus.com/inward/record.url?scp=0032869185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032869185&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 539

EP - 552

JO - Neuroimaging Clinics of North America

JF - Neuroimaging Clinics of North America

SN - 1052-5149

IS - 3

ER -